v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of risks (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Concentration of risks      
Research and development $ 45,377 $ 29,939 $ 24,844
Cash and cash equivalents 352,932 31,677  
Cash deposit 337,291 31,677  
Cash, Uninsured Amount 334,557    
Non-US      
Concentration of risks      
Cash and cash equivalents 84,390 21,469  
Research and development expense | Supplier concentration risk | A      
Concentration of risks      
Research and development   5,010 7,941
Research and development expense | Supplier concentration risk | B      
Concentration of risks      
Research and development 10,802 5,846 $ 6,926
Research and development expense | Supplier concentration risk | C      
Concentration of risks      
Research and development 4,987    
Cash | Geographic concentration risk | UNITED STATES      
Concentration of risks      
Cash and cash equivalents $ 252,901 $ 10,208  
Cash and Cash Equivalents | Credit Concentration Risk | Single Financial Institution In United States      
Concentration of risks      
Concentration Risk, Percentage 70.00%